Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages 1515-1521

  Paximadis, Peter ^a   Yoo, George ^b   Lin, Ho Sheng ^b   Jacobs, John ^b   Sukari, Ammar ^b   Dyson, Greg ^b   Christensen, Michael ^a   Kim, Harold ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Chemoradiotherapy; Head and neck cancer; Hypopharyngeal cancer; Hypopharynx; Laryngeal function

Indexed keywords

CONCURRENT CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; GASTROSTOMY; HEAD-AND-NECK CANCER; HYPOPHARYNGEAL CANCER; HYPOPHARYNX; INDUCTION CHEMOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; LOCAL CONTROL; LOCAL RECURRENCE; OVERALL SURVIVAL; PERSISTENT DISEASE; SURVIVAL RATE; TREATMENT MODALITY;

CATHODE RAY TUBES; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; PATIENT MONITORING; RADIOTHERAPY; SURGERY;

CHEMORADIOTHERAPY;

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROSTOMY; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INDUCTION CHEMOTHERAPY; LARYNX; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857923478     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.064     Document Type: Article

References (19)

1. J.L. Lefebvre, D. Chevalier, and B. Luboinski Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial J Natl Cancer Inst 88 1996 890 899
2. The Department of Veterans Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
3. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
4. D.J. Adelstein, G.L. Adams, and H. Wagner An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
5. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
6. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
7. J.L. Lefebvre, and K.K. Ang Larynx preservation clinical trial design: Key issues and recommendations - A consensus panel summary Int J Radiat Oncol Biol Phys 73 2009 1293 1303
8. A.S. Garden, W.H. Morrison, and G.L. Clayman Early squamous cell carcinoma of the hypopharynx: Outcomes of treatment with radiation alone to the primary disease Head Neck 18 1996 317 322
9. R.J. Amdur, W.M. Mendenhall, and S.P. Stringer Organ preservation with radiation therapy for T1-T2 carcinoma of the pyriform sinus Head Neck 23 2001 353 362
10. R.Y. Yoshimura, Y. Kagami, and Y. Ito Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 77 2010 1017 1023
11. R.J. Bensadoun, K. Benezery, and O. Dassonville French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at two years (FNCLCC-GORTEC) Int J Radiat Oncol Biol 64 2006 983 994
12. J.M. Prades, B. Lallemant, and R. Garrel Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma Acta Otolaryngol 130 2010 150 155
13. M.S. Yoon, W.K. Chung, and S.J. Ahn Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal cancer Acta Otolaryngol 128 2008 590 596
14. L. Lambert, B. Fortin, and D. Soulieres Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: Are we succeeding? Int J Radiat Oncol Biol 76 2010 398 402
15. W.T. Lee, L.M. Akst, and D.J. Adelstein Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation Head Neck 28 2006 808 812
16. A. Eisbruch, M. Schwartz, and C. Rasch Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol 60 2004 1425 1439
17. F.Y. Felix, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol 68 2007 1289 1298
18. N.Y. Lee, W. O'Meara, and K. Chan Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers Int J Radiat Oncol Biol 69 2007 459 468
19. G. Studer, E. Peponi, and S. Kloeck Surviving hypopharynx-larynx carcinoma in the era of IMRT Int J Radiat Oncol Biol 77 2010 1391 1396